ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 656,07
1,13%
Dow Jones
38 958,62
0,32%
DAX
18 188,44
0,67%
Brent Oil
85,205
0,60%
Bitcoin
65 066,80
0,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neovasc Inc (NVCN)

  7. Neovasc Inc (NVCN) Actualités

NVCN

Neovasc (NVCN)

Neovasc Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NVCN
DateHeureSourceTitreSymboleSociété
03/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NVCNNeovasc Inc
24/04/202322h15Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:NVCNNeovasc Inc
12/04/202319h11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
11/04/202315h11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVCNNeovasc Inc
11/04/202315h08Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)NASDAQ:NVCNNeovasc Inc
11/04/202315h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NVCNNeovasc Inc
11/04/202315h06Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVCNNeovasc Inc
11/04/202314h48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:NVCNNeovasc Inc
11/04/202314h20GlobeNewswire Inc.Shockwave Medical Completes Acquisition of NeovascNASDAQ:NVCNNeovasc Inc
31/03/202322h11GlobeNewswire Inc.Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
06/03/202323h37GlobeNewswire Inc.Neovasc Shareholders Approve Acquisition by Shockwave MedicalNASDAQ:NVCNNeovasc Inc
01/02/202315h05GlobeNewswire Inc.Neovasc Announces German Reimbursement RenewalNASDAQ:NVCNNeovasc Inc
17/01/202314h00GlobeNewswire Inc.Shockwave Medical to Acquire NeovascNASDAQ:NVCNNeovasc Inc
17/01/202314h00GlobeNewswire Inc.Shockwave Medical Announces Agreement to Acquire NeovascNASDAQ:NVCNNeovasc Inc
28/11/202222h45GlobeNewswire Inc.Neovasc Announces Progress on COSIRA-II Clinical TrialNASDAQ:NVCNNeovasc Inc
18/11/202215h05GlobeNewswire Inc.Neovasc Comments on European Heart Journal PublicationNASDAQ:NVCNNeovasc Inc
15/11/202212h45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
10/11/202222h05GlobeNewswire Inc.Neovasc Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
08/11/202215h05GlobeNewswire Inc.Neovasc Reducer Obtains U.S. Outpatient ReimbursementNASDAQ:NVCNNeovasc Inc
27/10/202215h00GlobeNewswire Inc.Neovasc to Report Third Quarter Financial Results on November 10, 2022NASDAQ:NVCNNeovasc Inc
20/09/202215h05GlobeNewswire Inc.Neovasc Provides Corporate Update Following Clinical Data ReleaseNASDAQ:NVCNNeovasc Inc
16/09/202215h00GlobeNewswire Inc.Neovasc to Participate in LSI Europe 2022 Emerging MedTech SummitNASDAQ:NVCNNeovasc Inc
15/09/202215h05GlobeNewswire Inc.Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory AnginaNASDAQ:NVCNNeovasc Inc
08/09/202215h05GlobeNewswire Inc.Neovasc Announces Key Events at TCT 2022NASDAQ:NVCNNeovasc Inc
30/08/202215h05GlobeNewswire Inc.Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVCNNeovasc Inc
22/08/202212h20TipRanksAnalysts Offer Insights on Healthcare Companies: Freeline Therapeutics Holdings (FRLN), Cabaletta Bio (CABA) and Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
11/08/202222h05GlobeNewswire Inc.Neovasc Announces Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
28/07/202215h00GlobeNewswire Inc.Neovasc to Report Second Quarter Financial Results on August 11, 2022NASDAQ:NVCNNeovasc Inc
26/07/202215h05GlobeNewswire Inc.Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsNASDAQ:NVCNNeovasc Inc
05/07/202215h05GlobeNewswire Inc.Neovasc Announces Direct Sales Operations in United KingdomNASDAQ:NVCNNeovasc Inc
 Showing the most relevant articles for your search:NASDAQ:NVCN

Dernières Valeurs Consultées

BIT
FECOMM
Vontobel Financial Produ...
EU
XS2696138150
GraniteShares 3x Short F...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés